FIELD: biotechnology.
SUBSTANCE: invention can be used in human and veterinary medicine for construction and production of highly efficient vaccines.
EFFECT: invention enables to create vaccines with low toxicity, increased immunogenic activity, and stable in storage.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING VACCINE ADJUVANT IN FORM OF EMULSION | 2022 |
|
RU2811696C1 |
| OLIGOHITOZANE DERIVATIVES AS ADJUVANTS FOR VACCINES | 2015 |
|
RU2589702C1 |
| ADJUVANT FOR ANTI-VIRAL VACCINES | 2017 |
|
RU2676266C2 |
| APPLICATION OF AETHONIUM AS ADJUVANT FOR PRODUCTION OF SORBED FOOT-MOUTH DISEASE VACCINE | 2013 |
|
RU2521513C1 |
| METHOD FOR PREVENTING ESCHERICHIOSIS IN CALVES | 2021 |
|
RU2766249C1 |
| METHOD FOR OBTAINING A SPECIFIC IMMUNOMODULATOR | 2021 |
|
RU2764467C1 |
| METHOD FOR PREVENTING ESCHERICHIOSIS IN PIGLETS | 2021 |
|
RU2766549C1 |
| ADJUVANT, BASED ON LOW-MOLECULAR PEPTIDOGLYCAN OF BACTERIAL CELL WALL | 2013 |
|
RU2563354C2 |
| VACCINE AND METHOD FOR INCREASING IMMUNOGENICITY AND SPECIFIC ACTIVITY OF INFECTION PREVENTION AGENTS | 2020 |
|
RU2741834C1 |
| OBTAINING A MICRO/NANOADJUVANT BASED ON RIZEDRONATE ZINC AND ITS USE AS A VACCINE ADJUVANT | 2020 |
|
RU2797509C1 |
Authors
Dates
2015-05-10—Published
2014-09-11—Filed